It should also be noted that the new study was conducted in patients with pre-existing Alzheimer's; therefore improvements would be difficult or impossible to measure.  Unfortunately there is no cure for Alzheimer's. There is, however, a large body of research investigating fatty fish consumption and supplementation with fish oil, which supports possible benefits of EPA and DHA in maintaining a healthy cognitive state.  Most research to date suggests that intervention is most effective at the earliest stages of cognitive decline or even before impairment is observed.

Of course the real loser in all this is the consumer, who now must attempt to compare this inaccurate, selectively reported information with the previous positive research papers published on Omega-3 EPA and DHA from fish oil.

What we do know is that Omega-3 EPA and DHA is perhaps the biggest dietary deficiency in the western diet. So much so that the EU Health Authorities recently established a Dietary Reference Value (DRV) of 250mg per day of EPA and DHA.  They have also recently issued positive assessments on several health claims for EPA and DHA. In addition, it is also expected that updated Dietary Guidelines for Americans scheduled to be issued in December will include recommendations for the daily intake of fatty fish equivalent to 250mg EPA plus DHA per day. There is a health care crisis in North America and we look forward to continued future findings from credible studies looking at the potential benefits of combined Omega-3 EPA and DHA in improving health and well being.

Source: OCEAN NUTRITION CANADA LTD.